secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001193125-24-239251
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics shareholders reject liquidation and dissolution plan
------------------------------------------------------------------------

- Proposal to approve dissolution received 13,938,893 FOR and 18,075,579 AGAINST; not approved.
- Proposal to adjourn for additional proxy solicitation also failed: 14,036,711 FOR vs 17,977,422 AGAINST.
- Company has discontinued business activities and lacks resources; board to explore alternatives.
- Special meeting held October 17, 2024; 32,061,280 shares (58.94% of outstanding) represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524239251/0001193125-24-239251-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524239251/d899671d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-239251

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer